Ocular Therapeutix, Inc. (OCUL)
10.78
-0.30
(-2.71%)
USD |
NASDAQ |
Aug 24, 16:00
10.78
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix 1 Year Total Returns (Daily) : -12.36% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | -12.36% |
| August 21, 2026 | -8.66% |
| August 20, 2026 | -7.27% |
| August 19, 2026 | -3.38% |
| August 18, 2026 | -10.56% |
| August 17, 2026 | -15.61% |
| August 14, 2026 | -20.63% |
| August 13, 2026 | -19.20% |
| August 12, 2026 | -18.00% |
| August 11, 2026 | -22.29% |
| August 10, 2026 | -24.32% |
| August 07, 2026 | -25.28% |
| August 06, 2026 | -30.08% |
| August 05, 2026 | -29.17% |
| August 04, 2026 | -30.45% |
| August 03, 2026 | -29.53% |
| July 31, 2026 | -29.45% |
| July 30, 2026 | -27.36% |
| July 29, 2026 | -28.85% |
| July 28, 2026 | -30.05% |
| July 27, 2026 | -29.24% |
| July 24, 2026 | -28.65% |
| July 23, 2026 | -27.93% |
| July 22, 2026 | -25.67% |
| July 21, 2026 | -22.45% |
| Date | Value |
|---|---|
| July 20, 2026 | -23.12% |
| July 17, 2026 | -21.18% |
| July 16, 2026 | -18.53% |
| July 15, 2026 | -10.19% |
| July 14, 2026 | -13.93% |
| July 13, 2026 | -10.43% |
| July 10, 2026 | -7.94% |
| July 09, 2026 | -2.04% |
| July 08, 2026 | 3.53% |
| July 07, 2026 | 7.49% |
| July 06, 2026 | 0.42% |
| July 02, 2026 | 1.90% |
| July 01, 2026 | 4.07% |
| June 30, 2026 | 5.82% |
| June 29, 2026 | 7.38% |
| June 26, 2026 | 4.02% |
| June 25, 2026 | 6.20% |
| June 24, 2026 | 8.36% |
| June 23, 2026 | 20.85% |
| June 22, 2026 | 22.63% |
| June 18, 2026 | 13.21% |
| June 17, 2026 | 16.14% |
| June 16, 2026 | 2.17% |
| June 15, 2026 | 2.98% |
| June 12, 2026 | -0.11% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| EyePoint, Inc. | -58.83% |
| LENZ Therapeutics, Inc. | -88.52% |
| Merck & Co., Inc. | 78.24% |
| Theravance Biopharma, Inc. | 22.29% |
| ANI Pharmaceuticals, Inc. | -18.50% |